课题基金 / 基金详情

Activation of extrinsic coagulation on tumor cell

Activation of extrinsic coagulation on tumor cell
肿瘤细胞外源性凝血的激活
批准号:
02670457
负责人:
SAKAI Toshiyuki
金额:
$1.54万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1990
资助国家:
日本
项目状态:
已结题
起止时间:
1990 至 1992

项目摘要

项目成果

SAKAI Toshiyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have studied the binding of radioiodinated human factors VII and VIIa to a human bladder carcinoma cell line (J82) that expresses functional cell surface tissue factor. The binding of factors VII and VIIa was found to be time-, temperature-, and calcium-dependent. The binding isotherms for factors VII and VIIa were hyperbolic, Kd values were 3.20 and 3.25 nM, respectively. Binding of factor VIIa to the cells was completely blocked by preincubation of the cells with anti-tissue factor IgG. Functional studies revealed that factor X activation by increasing amounts of cell-bound factor VII or VIIa was hyperbolic. Half maximal rates occurred at factor VII and VIIa concentrations of 3.7 and 3.2 nM, respectively. The offered ^<125>I-factor VII was progressively converted to two-chain factor VIIa upon binding to the cells. Specific binding of factor VIIa lacking the gamma-carboxyglutamic acid domain (GD-VIIa) to J82 was neither influenced by calcium nor blocked by prior incubation of the cells with anti-tissue factor IgG. These results indicate that the gamma-carboxyglutamic acid domain of factor VIIa is essential for its interaction with cell surface tissue factor. We have next examined the ability of four human tumor cell lines to augment the conversion of prothrombin to thrombin by factor Xa and calcium. The order of effectiveness was COLO 205>HepG2>J82>CAPAN-2. Furthermore, factor Xa bound specifically to J82 and HepG2 cells, whereas no significant specific binding of factor X to either cell was observed. Kd values were 1.66nM(HepG2) and 1.64nM(J82). Thrombin formation by cell-bound factor Xa was hyperbolic and saturable at 5nM factor Xa on each cell line. Our results indicate that these tumor cells can readily assemble a functional cell surface prothrombinase complex that may be important in fibrin deposition associated with the growth and metastatic progression of these, and perhaps, other tumors.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
SakaiT,KisielW.et al: "Binding of human factors VII and VIIa to a human bladder carcinoma cell line(J82)" J.Biol.Chem.264. 9980-9988 (1989)
SakaiT,KisielW.et al:“人因子 VII 和 VIIa 与人膀胱癌细胞系 (J82) 的结合”J.Biol.Chem.264。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sakai T,Kisiel W,et al.: "Tumor cells augment the factor Va-catalyzed conversion of prothrombin to thrombin" Haemostasis. 20. 125-135 (1990)
Sakai T、Kisiel W 等人:“肿瘤细胞增强 Va 因子催化的凝血酶原向凝血酶的转化” 止血。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sakai T,Kisiel W et al: "Tumor cells augment the factor Xaーcatalyzed conversion of prothrombin to thrombin" Haemostasis. 20. 125-135 (1990)
Sakai T、Kisiel W 等人:“肿瘤细胞增强 Xa 因子催化的凝血酶原向凝血酶的转化”《止血》20. 125-135 (1990)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sakai T: "Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82)" J. Biol. Chem.264. 9980-9988 (1989)
Sakai T:“人因子 VII 和 VIIa 与人膀胱癌细胞系 (J82) 的结合”J. Biol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
8
    Application of molecular-targeting cancer prevention to human intervention study.
    • 批准号:
      15H02529
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $29.29万
    • 财政年份:
      2015
    • 负责人:
      SAKAI Toshiyuki
    • 依托单位:
    Novel molecular-targeting prevention of cancer by sensitizing the effect of sodium butyrate
    • 批准号:
      23659336
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      SAKAI Toshiyuki
    • 依托单位:
    Development of micrRNA-targeting cancer prevention
    • 批准号:
      21249042
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $28.29万
    • 财政年份:
      2009
    • 负责人:
      SAKAI Toshiyuki
    • 依托单位:
    Research on a selection reference of chemopreventive agents for cancer and a development of tailor-made medicine for cancer prevention
    • 批准号:
      17209022
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.87万
    • 财政年份:
      2005
    • 负责人:
      SAKAI Toshiyuki
    • 依托单位:
    海外基金